3041B |
Metoclopramide, Blood |
3041SP |
Metoclopramide, Serum/Plasma |
3041U |
Metoclopramide, Urine |
3060U |
N,N-Dimethylacetamide Exposure (N-Methylacetamide), Urine |
3064B |
Mitragynine, Blood |
3064SP |
Mitragynine, Serum/Plasma |
3070U |
N,N-Dimethylformamide (DMF) Exposure (N-Monomethylformamide), Urine |
3078U |
Mitragynine (Qualitative), Urine |
3080U |
MOCA, Urine |
3081U |
MOCA and MDA Exposure Profile, Urine |
3098U |
Mono-n-butyl phthalate (MNBP), Urine |
3168B |
Nitazenes Panel, Blood |
3218B |
N,N-Dimethylpentylone & Pentylone, Blood |
3218SP |
N,N-Dimethylpentylone & Pentylone, Serum/Plasma |
3218U |
N,N-Dimethylpentylone & Pentylone, Urine |
3224B |
NPS Stimulants (Qualitative), Blood |
3224SP |
NPS Stimulants (Qualitative), Serum/Plasma |
3224U |
NPS Stimulants (Qualitative), Urine |
3232B |
Omeprazole / Esomeprazole, Blood |
3232SP |
Omeprazole / Esomeprazole, Serum/Plasma |
3690B |
Phentermine, Blood |
3690SP |
Phentermine, Serum/Plasma |
3690U |
Phentermine, Urine |